GPR108, an NF-[kappa]B activator suppressed by TIRAP, negatively regulates TLR-triggered immune responses

• Published in: PloS one Vol. 13; no. 10; p. e0205303
• Main Authors: Dong, Danfeng, Zhou, Haisheng, Na, Soon-Young, Niedra, Rasma, Peng, Yibing, Wang, Huajun, Seed, Brian, Zhou, Guo Ling
• Format: Journal Article
• Language: English
• Published: Public Library of Science 17.10.2018
• Subjects: Cellular signal transduction; Immune system; Phylogeny
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0205303

Higher vertebrates have evolved innate and adaptive immune systems to defend against foreign substances and pathogens. Sophisticated regulatory circuits are needed to avoid inappropriate immune responses and inflammation. GPR108 is a seven-transmembrane family protein that activates NF-[kappa]B strongly when overexpressed. Surprisingly, its action in a physiological context is that of an antagonist of Toll-like receptor (TLR)-mediated signaling. Cells from Gpr108-null mice exhibit enhanced cytokine secretion and NF-[kappa]B and IRF3 signaling, whereas Gpr108-null macrophages reconstituted with GPR108 exhibit blunted signaling. Co-expression of TLRs and GPR108 reduces NF-[kappa]B and IFN[beta] promoter activation compared to expression of either TLRs or GPR108 alone. Upon TLR stimulation GPR108 abundance increases and the protein engages TLRs and their partners to reduce MyD88 expression and interfere with its binding to TLR4 through blocking MyD88 ubiquitination. In turn GPR108 is antagonized by TIRAP, an adaptor protein for TLR and MyD88. The interrelationships between GPR108 and innate immune signaling components are multifactorial and point to a membrane-associated signaling structure of significant complexity.